Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5528158 | Lung Cancer | 2017 | 13 Pages |
Abstract
The lack of survival benefit in patients with small-cell lung cancer taking long-term aspirin may be due to the low expression of cyclooxygenase-2 in small-cell lung cancer tissue.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Paul Maddison,